ALLO
Price
$2.64
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
20 days until earnings call
VRDN
Price
$22.77
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
32 days until earnings call
Ad is loading...

ALLO vs VRDN

Header iconALLO vs VRDN Comparison
Open Charts ALLO vs VRDNBanner chart's image
Allogene Therapeutics
Price$2.64
Change-$0.00 (-0.00%)
Volume$1.46M
CapitalizationN/A
Viridian Therapeutics
Price$22.77
Change-$0.00 (-0.00%)
Volume$790.77K
CapitalizationN/A
View a ticker or compare two or three
ALLO vs VRDN Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALLO vs. VRDN commentary
Oct 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Buy and VRDN is a StrongSell.

COMPARISON
Comparison
Oct 11, 2024
Stock price -- (ALLO: $2.64 vs. VRDN: $22.77)
Brand notoriety: ALLO and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 70% vs. VRDN: 49%
Market capitalization -- ALLO: $608.51M vs. VRDN: $1.78B
ALLO [@Biotechnology] is valued at $608.51M. VRDN’s [@Biotechnology] market capitalization is $1.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, VRDN is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 6 TA indicator(s) are bullish while VRDN’s TA Score has 6 bullish TA indicator(s).

  • ALLO’s TA Score: 6 bullish, 3 bearish.
  • VRDN’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than VRDN.

Price Growth

ALLO (@Biotechnology) experienced а +4.35% price change this week, while VRDN (@Biotechnology) price change was -6.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ALLO is expected to report earnings on Feb 26, 2025.

VRDN is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.78B) has a higher market cap than ALLO($609M). VRDN YTD gains are higher at: 4.545 vs. ALLO (-17.757). VRDN has higher annual earnings (EBITDA): -224.78M vs. ALLO (-256.56M). VRDN has more cash in the bank: 571M vs. ALLO (445M). VRDN has less debt than ALLO: VRDN (21M) vs ALLO (87M). VRDN has higher revenues than ALLO: VRDN (288K) vs ALLO (65K).
ALLOVRDNALLO / VRDN
Capitalization609M1.78B34%
EBITDA-256.56M-224.78M114%
Gain YTD-17.7574.545-391%
P/E RatioN/AN/A-
Revenue65K288K23%
Total Cash445M571M78%
Total Debt87M21M414%
FUNDAMENTALS RATINGS
ALLO vs VRDN: Fundamental Ratings
ALLO
VRDN
OUTLOOK RATING
1..100
1021
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
10066
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
5335
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VRDN's Valuation (95) in the Biotechnology industry is in the same range as ALLO (97). This means that VRDN’s stock grew similarly to ALLO’s over the last 12 months.

VRDN's Profit vs Risk Rating (66) in the Biotechnology industry is somewhat better than the same rating for ALLO (100). This means that VRDN’s stock grew somewhat faster than ALLO’s over the last 12 months.

ALLO's SMR Rating (96) in the Biotechnology industry is in the same range as VRDN (98). This means that ALLO’s stock grew similarly to VRDN’s over the last 12 months.

VRDN's Price Growth Rating (35) in the Biotechnology industry is in the same range as ALLO (53). This means that VRDN’s stock grew similarly to ALLO’s over the last 12 months.

VRDN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ALLO (100). This means that VRDN’s stock grew similarly to ALLO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALLOVRDN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL229.543.77
+1.67%
Apple
SPY577.143.97
+0.69%
SPDR® S&P 500® ETF Trust
GME20.50-0.21
-1.01%
GameStop Corp
TSLA241.05-3.45
-1.41%
Tesla
BTC.X60582.100000-1549.867200
-2.49%
Bitcoin cryptocurrency

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with ALLO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-2.69%
ALLO - VRDN
51%
Loosely correlated
-3.65%
FATE - VRDN
49%
Loosely correlated
-1.95%
ABCL - VRDN
48%
Loosely correlated
-3.11%
CRBU - VRDN
45%
Loosely correlated
-2.12%
VIR - VRDN
44%
Loosely correlated
+0.14%
More